quinoxalines has been researched along with Delayed Hypersensitivity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cole, SH; Gladue, RP; McNeish, JD; Nelson, RT; Neote, KS; Ogborne, KT; Roach, ML; Shepard, RM; Tylaska, LA | 1 |
1 other study(ies) available for quinoxalines and Delayed Hypersensitivity
Article | Year |
---|---|
The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice.
Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Migration Inhibition; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokines, CC; Chemotaxis, Leukocyte; Cytokines; Humans; Hypersensitivity, Delayed; Macrophage Inflammatory Proteins; Mice; Mice, Inbred DBA; Mice, Transgenic; Quinoxalines; Receptors, CCR1; Receptors, Chemokine; Stem Cells; Th1 Cells | 2006 |